The Belgian Endothelial Surgical Transplant of the Cornea (BESTCornea)

A

Antwerp University Hospital (UZA)

Status

Enrolling

Conditions

Corneal Edema
Bullous Keratopathy
Corneal Endothelial Disorder
Fuchs' Endothelial Dystrophy
Pseudophakic Bullous Keratopathy

Treatments

Procedure: DMEK
Procedure: DSAEK

Study type

Interventional

Funder types

Other

Identifiers

NCT05436665
UZAntwerpen

Details and patient eligibility

About

This study is designed as a randomised multicentric parallel group pragmatic trial of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK) in corneal endothelial decompensation. the purpose is to compare the clinical and patient reported outcomes of both therapies across a broad range of indications.

Full description

The current problem concerns variability in the provision of corneal endothelial keratoplasties available to patients in Belgium. Some patients receive DSAEK and some (albeit fewer) receive DMEK. Currently the type of corneal graft that a patient receives depends on the treating surgeon opinions. In this study 220 patients in 11 surgical centres will be recruited and allocated to one of the two surgical options. Both the Ultrathin DSAEK and DMEK grafts will be prepared by corneal banks in the University Hospital of Liege and University Hospital of Antwerp respectively. Patients will be examined preoperatively and postoperatively at 3, 6 and 12 months. Clinical information such as best-corrected visual acuity and refraction will be collected as well as quality of life information based on the EQ-5D-5L and the VFQ 25 assessment tools. These data be used to compare the interventions both on the clinical level as well as from the patient perspective.

Enrollment

220 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Fuchs Endothelial Dystrophy (FED);
  • Bullous Keratopathy (BK);
  • Other miscellaneous causes of endothelial dysfunction including decompensation of a previous corneal graft;
  • Pseudophakic (post cataract surgery);
  • Patients over 18 with the capacity to read and to understand the study information and to give informed consent, as well as study quality of life questionnaires;
  • Patients willing and capable to attend the 3, 6, and 12-month follow-up appointments.

Exclusion criteria

  • Inability to provide informed consent;
  • Patients unable to attend the proposed follow up;
  • Inclusion of the fellow eye in the study;
  • Complex surgery combined with multiple pathologies (i.e., glaucoma surgery);
  • Other contraindications to lamellar corneas surgery;
  • Patients who elect not to participate;
  • Patients under 18 years of age;
  • Patients that are currently pregnant or breastfeeding;
  • Phakic patients with no direct plan to perform cataract surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

220 participants in 2 patient groups

UT-DSAEK
Active Comparator group
Description:
Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty refers to the use of a corneal endothelial/Descemet graft with a thin layer of stroma (<110um) attached.
Treatment:
Procedure: DSAEK
DMEK
Active Comparator group
Description:
Descemet membrane endothelial keratoplasty refers to the use of a corneal endothelial/Descemet graft with no layer of associated stroma (15-20um thick)
Treatment:
Procedure: DMEK

Trial contacts and locations

11

Loading...

Central trial contact

Veerle Van Gerwen, BSc; Ann Deconinck, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems